Advertisement

Comprehensive Drug Screening by Thermal Desorption and Pyrolysis Combined with Direct Analysis in Real Time-Mass Spectrometry (TDP/DART-MS)

  • Hiroko Abe
  • Chikako Takei
  • Motoshi Sakakura
  • Daisuke Yajima
  • Hirotato Iwase
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1810)

Abstract

Rapid and accurate analysis of drugs using direct analysis in real time-mass spectrometry (DART-MS) combined with thermal desorption pyrolysis (TDP/DART-MS) is described in this chapter. Rapid drug screening is very important in cases of suspected drug abuse. However, acquiring accurate analytical data requires highly optimized sample handling and technical expertise. Although rapid drug analysis using mass spectrometry provides reliable data, it is not commonly used because of its complexity. Thus, a comprehensive analysis system for drugs that requires minimal optimization of sample preparation and analytical conditions is strongly desired. DART-MS involves ambient ionization mass spectrometric analysis with little to no sample preparation. We have coupled this approach with thermal TDP/DART-MS and demonstrate how it can be used to detect drugs in complex matrices such as urine or blood.

Key words

DART TDP/DART-MS Mass spectrometry Drug screening Comprehensive drug screening Illegal drugs 

References

  1. 1.
    Buechler KF et al (1992) Simultaneous detection of seven drugs of abuse by the triage panel for drugs of abuse. Clin Chem 38(9):1678–1684PubMedGoogle Scholar
  2. 2.
    Phillips JE, Bogema S, Fu P, Furmaga W, Wu AHB, Zic V, Hammett-Stabler C (2003) Signify® ER drug screen test evaluation: comparison to triage® drug of abuse panel plus tricyclic antidepressants. Clin Chim Acta 328:31–38CrossRefPubMedGoogle Scholar
  3. 3.
    Moody DE, Fang WB, Andrenyak DM, Monti KM, Jones C (2006) A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry. J Anal Toxicol 30(1):50–56CrossRefPubMedGoogle Scholar
  4. 4.
    Strano-Rossi S, Molaioni F, Rossi F, Botrè F (2005) Rapid screening of drugs of abuse and their metabolites by gas chromatography/mass spectrometry: application to urinalysis. Rapid Commun Mass Spectrom 19(11):1529–1535CrossRefPubMedGoogle Scholar
  5. 5.
    Moeller MR, Steinmeyer S, Kraemer T (1998) Determination of drugs of abuse in blood. J Chromatogr B Biomed Sci Appl 713(1):91–109CrossRefPubMedGoogle Scholar
  6. 6.
    Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M (2005) Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom 19(10):1332–1338CrossRefPubMedGoogle Scholar
  7. 7.
    Maurer HH (2005) Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Clin Biochem 38(4):310–318CrossRefPubMedGoogle Scholar
  8. 8.
    Pavloich MJ, Musselman B, Hall AB (2016) Direct analysis in real time—mass spectrometry (DART-MS) in forensic and security applications. Mass Spectrom Rev 37(2):171–187CrossRefGoogle Scholar
  9. 9.
    Cody RB, Laramée JA, Durst HD (2005) Versatile new ion source for the analysis of materials in open air under ambient conditions. Anal Chem 77(8):2297–2302CrossRefPubMedGoogle Scholar
  10. 10.
    BioChromato, Inc (2017). https://biochromato.com/ionrocket/. Accessed 10 Apr 2017
  11. 11.
    Hiroko A, Chikako T et al (2016) Illegal drugs analysis by thermal desorption and pyrolysis combined with direct analysis in real time-mass spectrometry (TDP/DART-MS). In: Abstract of 64th American Society for Mass Spectrometry (ASMS) annual conference, Henry B. Gonzalez Convention Center, Texas, 5–9 June 2016Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Hiroko Abe
    • 1
  • Chikako Takei
    • 2
  • Motoshi Sakakura
    • 3
  • Daisuke Yajima
    • 1
  • Hirotato Iwase
    • 1
    • 4
  1. 1.Department of Legal Medicine, Graduate School of MedicineChiba UniversityChiba-shiJapan
  2. 2.BioChromato, Inc.Fujisawa-shiJapan
  3. 3.AMR, Inc.Meguro-kuJapan
  4. 4.Department of Forensic Medicine, Graduate School of MedicineThe University of TokyoTokyoJapan

Personalised recommendations